TASK channel deletion reduces sensitivity to local anesthetic-induced seizures

Anesthesiology

Volumn 115, Issue 5, 2011, Pages 1003-1011

  Du, Guizhi ^a   Chen, Xiangdong ^a   Todorovic, Marko S ^b   Shu, Shaofang ^c   Kapur, Jaideep ^b   Bayliss, Douglas A ^c  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LIDOCAINE; PICROTOXIN; POTASSIUM CHANNEL TASK 1; POTASSIUM CHANNEL TASK 2; ROPIVACAINE; TANDEM PORE DOMAIN POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE DURATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG POTENCY; DRUG SENSITIVITY; ELECTROENCEPHALOGRAM; IC 50; INCIDENCE; MOUSE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SINGLE DRUG DOSE; TONIC CLONIC SEIZURE;

EID: 80055025058     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182343660     Document Type: Article

References (50)

1. Catterall WA, Mackie K: Goodman and Gilman's The Pharmacological Basis of Therapeutics, Local Anesthetics, 12th edition. Edited by Brunton LL, Chabner BA, Knollmann BC. New York, McGraw-Hill, 2011, pp 565-582
2. Moraca RJ, Sheldon DG, Thirlby RC: The role of epidural anesthesia and analgesia in surgical practice. Ann Surg 2003; 238:663-73 (Pubitemid 38182256)
3. Koppert W, Weigand M, Neumann F, Sittl R, Schuettler J, Schmelz M, Hering W: Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg 2004; 98:1050-5 (Pubitemid 38405419)
4. Rowbotham MC, Reisner-Keller LA, Fields HL: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41:1024-8
5. Kingery WS: A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997; 73:123-39 (Pubitemid 27491673)
6. DiFazio CA, Neiderlehner JR, Burney RG: The anesthetic potency of lidocaine in the rat. Anesth Analg 1976; 55: 818-21
7. Himes RS Jr, DiFazio CA, Burney RG: Effects of lidocaine on the anesthetic requirements for nitrous oxide and halothane. Anesthesiology 1977; 47:437-40 (Pubitemid 8223101)
8. Pypendop BH, Ilkiw JE: The effects of intravenous lidocaine administration on the minimum alveolar concentration of isoflurane in cats. Anesth Analg 2005; 100:97-101 (Pubitemid 40013611)
9. Vandermeulen E: Systemic analgesia and co-analgesia. Acta Anaesthesiol Belg 2006; 57:113-20 (Pubitemid 44060662)
10. Pinter A, Dorian P: Intravenous antiarrhythmic agents. Curr Opin Cardiol 2001; 16:17-22 (Pubitemid 32060026)
11. Trujillo TC, Nolan PE: Antiarrhythmic agents: Drug interactions of clinical significance. Drug Saf 2000; 23:509-32 (Pubitemid 32001513)
12. Brown DL, Ransom DM, Hall JA, Leicht CH, Schroeder DR, Offord KP: Regional anesthesia and local anesthetic-induced systemic toxicity: Seizure frequency and accompanying cardiovascular changes. Anesth Analg 1995; 81:321-8
13. Graf BM: The cardiotoxicity of local anesthetics: The place of ropivacaine. Curr Top Med Chem 2001; 1:207-14
14. Feldman HS, Arthur GR, Covino BG: Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg 1989; 69:794-801 (Pubitemid 20041787)
15. Finucane BT: Ropivacaine cardiac toxicity-not as troublesome as bupivacaine. Can J Anaesth 2005; 52:449-53 (Pubitemid 40883302)
16. Akerman B, Hellberg IB, Trossvik C: Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103). Acta Anaesthesiol Scand 1988; 32: 571-8
17. +channels by local anesthetics. Science 1994; 265:1724-8 (Pubitemid 24314907)
18. Kindler CH, Yost CS: Two-pore domain potassium channels: New sites of local anesthetic action and toxicity. Reg Anesth Pain Med 2005; 30:260-74 (Pubitemid 40718909)
19. Talley EM, Solorzano G, Lei Q, Kim D, Bayliss DA: Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci 2001; 21:7491-505 (Pubitemid 32904948)
20. Karschin C, Wischmeyer E, Preisig-Mller R, Rajan S, Derst C, Grzeschik KH, Daut J, Karschin A: Expression pattern in brain of TASK-1, TASK-3, and a tandem pore domain K(+) channel subunit, TASK-5, associated with the central auditory nervous system. Mol Cell Neurosci 2001; 18:632-48 (Pubitemid 34060145)
21. Vega-Saenz de Miera E, Lau DH, Zhadina M, Pountney D, Coetzee WA, Rudy B: KT3.2 and KT3.3, two novel human two-pore K(+) channels closely related to TASK-1. J Neurophysiol 2001; 86:130-42 (Pubitemid 32623219)
22. Goldstein SA, Bockenhauer D, O'Kelly I, Zilberberg N: Potassium leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci 2001; 2:175-84 (Pubitemid 33673370)
23. Lesage F: Pharmacology of neuronal background potassium channels. Neuropharmacology 2003; 44:1-7 (Pubitemid 36135836)
24. +currents: Two-pore domain potassium channels. Physiol Rev 2010; 90:559-605
25. Kindler CH, Yost CS, Gray AT: Local anesthetic inhibition of baseline potassium channels with two pore domains in tandem. Anesthesiology 1999; 90:1092-102 (Pubitemid 29159768)
26. Mather LE, Copeland SE, Ladd LA: Acute toxicity of local anesthetics: Underlying pharmacokinetic and pharmacodynamic concepts. Reg Anesth Pain Med 2005; 30:553-66 (Pubitemid 41751033)
27. Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, Carey RM, Bayliss DA, Barrett PQ: TASK channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci USA 2008; 105:2203-8 (Pubitemid 351439489)
28. Lazarenko RM, Willcox SC, Shu S, Berg AP, Jevtovic-Todorovic V, Talley EM, Chen X, Bayliss DA: Motoneuronal TASK channels contribute to immobilizing effects of inhalational general anesthetics. J Neurosci 2010; 30:7691-704
29. Mulkey DK, Talley EM, Stornetta RL, Siegel AR, West GH, Chen X, Sen N, Mistry AM, Guyenet PG, Bayliss DA: TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity. J Neurosci 2007; 27:14049-58 (Pubitemid 351377868)
30. Perici D, Lazi J, Jazvinsak JM, Svob Strac D: Stimulation of 5-HT1A receptors increases the seizure threshold for picrotoxin in mice. Eur J Pharmacol 2005; 527:105-10 (Pubitemid 41745157)
31. Liu PL, Feldman HS, Giasi R, Patterson MK, Covino BG: Comparative CNS toxicity of lidocaine, etidocaine, bupivacaine, and tetracaine in awake dogs following rapid intravenous administration. Anesth Analg 1983; 62:375-9 (Pubitemid 13161142)
32. Rutten AJ, Nancarrow C, Mather LE, Ilsley AH, Runciman WB, Upton RN: Hemodynamic and central nervous system effects of intravenous bolus doses of lidocaine, bupivacaine, and ropivacaine in sheep. Anesth Analg 1989; 69:291-9 (Pubitemid 20033449)
33. Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R: Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69:563-9 (Pubitemid 20043242)
34. Dony P, Dewinde V, Vanderick B, Cuignet O, Gautier P, Legrand E, Lavand'homme P, De Kock M: The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats. Anesth Analg 2000; 91:1489-92
35. Barker JL, McBurney RN, Mathers DA: Convulsant-induced depression of amino acid responses in cultured mouse spinal neurones studied under voltage clamp. Br J Pharmacol 1983; 80:619-29 (Pubitemid 14204625)
36. Aller MI, Veale EL, Linden AM, Sandu C, Schwaninger M, Evans LJ, Korpi ER, Mathie A, Wisden W, Brickley SG: Modifying the subunit composition of TASK channels alters the modulation of a leak conductance in cerebellar granule neurons. J Neurosci 2005; 25:11455-67 (Pubitemid 43083717)
37. Brickley SG, Aller MI, Sandu C, Veale EL, Alder FG, Sambi H, Mathie A, Wisden W: TASK-3 two-pore domain potassium channels enable sustained high-frequency firing in cerebellar granule neurons. J Neurosci 2007; 27:9329-40 (Pubitemid 47358198)
38. Yost CS, Oh I, Eger EI 2nd, Sonner JM: Knockout of the gene encoding the K(2P) channel KCNK7 does not alter volatile anesthetic sensitivity. Behav Brain Res 2008; 193:192-6
39. +channels. Curr Drug Targets 2003; 4:347-51 (Pubitemid 36443253)
40. +channel involved in neuroprotection and general anesthesia. EMBO J 2004; 23:2684-95 (Pubitemid 38988239)
41. Bayliss DA, Barrett PQ: Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact. Trends Pharmacol Sci 2008; 29:566-75
42. +channel TASK-2 (KCNK5). J Pharmacol Exp Ther 2003; 306:84-92 (Pubitemid 36734360)
43. +channel KCNK5 (TASK-2) in the rat central nervous system. Brain Res Mol Brain Res 2002; 98:153-63 (Pubitemid 34142291)
44. +(TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits. J Neurosci 2004; 24:6693-702 (Pubitemid 38993889)
45. Kang D, Han J, Talley EM, Bayliss DA, Kim D: Functional expression of TASK-1/TASK-3 heteromers in cerebellar granule cells. J Physiol 2004; 554:64-77 (Pubitemid 38081443)
46. +channel in rat carotid body glomus cells. J Physiol 2009; 587:2963-75
47. +-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. Mol Pharmacol 2006; 69:1468-76
48. Tucker GT: Pharmacokinetics of local anaesthetics. Br J Anaesth 1986; 58:717-31 (Pubitemid 16098076)
49. Moore PA, Hersh EV: Local anesthetics: Pharmacology and toxicity. Dent Clin North Am 2010; 54:587-99
50. Rousseau GF, Oram M, Barrington J, Priston M, Swart M: Plasma lidocaine concentrations following insertion of 2% lidocaine gel into the uterine cavity after uterine balloon thermal ablation. Br J Anaesth 2002; 89:846-8 (Pubitemid 35460522)